24713000|t|Tau phosphorylation and tau mislocalization mediate soluble Abeta oligomer-induced AMPA glutamate receptor signaling deficits.
24713000|a|In our previous studies, phosphorylation-dependent tau mislocalization to dendritic spines resulted in early cognitive and synaptic deficits. It is well known that amyloid beta (Abeta) oligomers cause synaptic dysfunction by inducing calcineurin-dependent AMPA receptor (AMPAR) internalization. However, it is unknown whether Abeta-induced synaptic deficits depend upon tau phosphorylation. It is also unknown whether changes in tau can cause calcineurin-dependent loss of AMPARs in synapses. Here, we show that tau mislocalizes to dendritic spines in cultured hippocampal neurons from APPSwe Alzheimer's disease (AD)-transgenic mice and in cultured rat hippocampal neurons treated with soluble Abeta oligomers. Interestingly, Abeta treatment also impairs synaptic function by decreasing the amplitude of miniature excitatory postsynaptic currents (mEPSCs). The above tau mislocalization and Abeta-induced synaptic impairment are both diminished by the expression of AP tau, indicating that these events require tau phosphorylation. The phosphatase activity of calcineurin is important for AMPAR internalization via dephosphorylation of GluA1 residue S845. The effects of Abeta oligomers on mEPSCs are blocked by the calcineurin inhibitor FK506. Abeta-induced loss of AMPARs is diminished in neurons from knock-in mice expressing S845A mutant GluA1 AMPA glutamate receptor subunits. This finding suggests that changes in phosphorylation state at S845 are involved in this pathogenic cascade. Furthermore, FK506 rescues deficits in surface AMPAR clustering on dendritic spines in neurons cultured from transgenic mice expressing P301L tau proteins. Together, our results support the role of tau and calcineurin as two intermediate signaling molecules between Abeta initiation and eventual synaptic dysfunction early in AD pathogenesis. 
24713000	60	65	Abeta	Gene	11820
24713000	236	267	cognitive and synaptic deficits	Disease	MESH:D003072
24713000	305	310	Abeta	Gene	11820
24713000	328	348	synaptic dysfunction	Disease	MESH:C536122
24713000	453	458	Abeta	Gene	11820
24713000	467	484	synaptic deficits	Disease	MESH:D009461
24713000	720	739	Alzheimer's disease	Disease	MESH:D000544
24713000	741	743	AD	Disease	MESH:D000544
24713000	756	760	mice	Species	10090
24713000	777	780	rat	Species	10116
24713000	822	827	Abeta	Gene	11820
24713000	854	859	Abeta	Gene	11820
24713000	1019	1024	Abeta	Gene	11820
24713000	1033	1052	synaptic impairment	Disease	MESH:D012183
24713000	1264	1269	GluA1	Gene	14799
24713000	1278	1282	S845	ProteinMutation	tmVar:p|Allele|S|845;VariantGroup:0;OriginalGene:14799;CorrespondingGene:2890;RS#:752389604;CorrespondingSpecies:10090
24713000	1299	1304	Abeta	Gene	11820
24713000	1366	1371	FK506	Chemical	MESH:D016559
24713000	1373	1378	Abeta	Gene	11820
24713000	1441	1445	mice	Species	10090
24713000	1457	1462	S845A	ProteinMutation	tmVar:p|SUB|S|845|A;HGVS:p.S845A;VariantGroup:0;OriginalGene:14799;CorrespondingGene:2890;RS#:752389604;CorrespondingSpecies:10090
24713000	1470	1475	GluA1	Gene	14799
24713000	1573	1577	S845	ProteinMutation	tmVar:p|Allele|S|845;VariantGroup:0;OriginalGene:14799;CorrespondingGene:2890;RS#:752389604;CorrespondingSpecies:10090
24713000	1632	1637	FK506	Chemical	MESH:D016559
24713000	1739	1743	mice	Species	10090
24713000	1755	1760	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
24713000	1885	1890	Abeta	Gene	11820
24713000	1915	1935	synaptic dysfunction	Disease	MESH:C536122
24713000	1945	1947	AD	Disease	MESH:D000544
24713000	Association	MESH:D016559	HGVS:p.P301L;CorrespondingGene:351
24713000	Negative_Correlation	MESH:D016559	11820
24713000	Association	MESH:D009461	11820
24713000	Positive_Correlation	MESH:D012183	11820
24713000	Association	MESH:C536122	11820

